封面
市场调查报告书
商品编码
1705899

CRISPR 技术市场:市场规模、份额、前景、按产品、应用、最终用户和地区分類的机会分析(2025 年至 2032 年)

CRISPR Technology Market, By Product, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: | 出版商: Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球 Crispr 技术市场规模估计为 36.562 亿美元,预计到 2032 年将达到 126.493 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 19.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 36.562亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 19.40% 2032年价值预测 126.493亿美元
数字。 2025 年 Crisprun 技术市场占有率(按地区)
CRISPR技术市场-IMG1

CRISPR技术正在推动医学、製药、生物技术和农业领域基因组编辑的进步,使世界各地的科学家能够透过更快、更有效率的基因组编辑来进行这些领域的研究。 CRISPR 也被用于纠正基因缺陷、治疗人类疾病和收穫更好的作物品种。 CRISPR 有许多潜在的应用,包括治疗或预防疾病传播、纠正基因缺陷和改良作物。 CRISPR-Cas9系统有广泛的应用。在医学上,它用于癌症、病毒感染、遗传疾病和病原体检测的研究。 CRISPR 是一种有可能改变世界的基因编辑技术。

市场动态:

全球范围内的 COVID-19 疫情爆发、正在进行的临床试验的增加以及对基因编辑工具的研究不断扩展是预计在预测期内促进全球 CRISPR 技术市场增长的关键因素。例如,2020 年 3 月,多伦多大学的科学家开发了 CHyMErA,这是一种基于 CRISPR 的更通用的基因组编辑工具。

CRISPR技术在COVID-19的防治上具有巨大的应用潜力。 2020 年 3 月,纽约基因组中心的研究人员开发了一种新的 CRISPR筛检技术,该技术针对 RNA,包括新型病毒(COVID-19)的 RNA。此外,2020 年 11 月,苏黎世瑞士联邦理工学院的研究人员以 CAS12a 取代了 CAS9 酶,使他们能够在 25 个目标位点编辑基因。

本研究的主要特点

  • 本报告对全球 CRISPR 技术市场进行了详细分析,并提供了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR),假设基准年为 2024 年。
  • 它还揭示了不同领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球 CRISPR 技术市场的主要企业会根据以下参数进行分析,例如公司亮点、产品系列、关键亮点、财务表现和策略。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球 CRISPR 技术市场报告迎合了该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球 CRISPR 技术市场的各种策略矩阵更轻鬆地做出决策。

目录:

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • CRISPR 的需求和应用不断增长
    • CRISPR的高成本
    • COVID-19(全球大流行)疫情
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球 CRISPR 技术市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球 CRISPR 技术市场(依产品划分)

  • 酵素
  • 套件和试剂
  • 嚮导RNA
  • 其他的

6. 全球 CRISPR 技术市场(按应用划分),2020 年至 2032 年

  • 生物医学
  • 农业
  • 产业
  • 其他的

7. 2020 年至 2032 年全球 CRISPR 技术市场(按最终用户划分)

  • 製药和生物技术公司
  • 学术和政府研究组织
  • 其他(CRO等)

8. 2020 年至 2032 年全球 CRISPR 技术市场(按地区)

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 其他国家

第九章 竞争态势

  • Merck KGaA
  • Thermo Fisher Scientific
  • Origene Technologies, Inc.
  • New England Biolabs
  • GenScript
  • GeneCopoeia, Inc.
  • Cellecta, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.(Horizon Discovery Ltd.)
  • Danaher Corporation(Integrated DNA Technologies)

第 10 章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第 11 章 章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI5175

Global Crispr Technology Market is estimated to be valued at USD 3,656.2 Mn in 2025 and is expected to reach USD 12,649.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 19.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3,656.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 19.40% 2032 Value Projection: USD 12,649.3 Mn
Figure. Crispr Technology Market Share (%), By Region 2025
CRISPR Technology Market - IMG1

CRISPR technology is driving advances in genome editing across medicine, pharmaceutical, biotechnology, and agriculture, which has enabled scientists to conduct research in these fields through faster and more efficient genome editing across the world. CRISPR is also used to correct genetic defects, treat human diseases, and yield better crop varieties. It has a number of potential applications that include treating and preventing the spread of diseases, correcting genetic defects, and also, improving crops. The CRISPR-Cas9 system has a wide diversity of applications. In medicine, it has been applied in research related to cancer, virus infections, genetic diseases and detection of pathogens. CRISPR is a technology that can be used to edit genes and, as such, will likely change the world.

Market Dynamics:

The outbreak of COVID-19 across the globe, increasing number of ongoing clinical trials, and expanding research in gene editing tools are some major factors expected to augment growth of the global CRISPR Technology market during the forecast period. For instance, in March 2020, scientists at the University of Toronto developed CHyMErA, a CRISPR-based tool for more versatile genome editing.

CRISPR technology have great potential for application in both the prevention and control of COVID-19. In March 2020, researchers at New York genome center developed a new CRISPR screening technology to target RNA, including RNA of novel viruses (COVID-19). Moreover, in November 2020, researchers at ETH Zurich, Switzerland, swapped CAS9 enzyme for CAS 12a, which allowed the researchers to edit genes in 25 target sites.

Key features of the study:

  • This report provides in-depth analysis of the global CRISPR Technology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global CRISPR Technology market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc., New England Biolabs, GenScript, GeneCopoeia, Inc., Cellecta, Inc., Agilent Technologies, Inc., PerkinElmer, Inc. (Horizon Discovery Ltd.), and Danaher Corporation (Integrated DNA Technologies), among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global CRISPR Technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR Technology market.

Detailed Segmentation:

  • Global CRISPR Technology Market, By Product:
    • Enzymes
    • Kits & Reagents
    • Guide RNA
    • Others
  • Global CRISPR Technology Market, By Application:
    • Biomedical
    • Agricultural
    • Industrial
    • Others
  • Global CRISPR Technology Market, By End User:
    • Pharmaceutical companies and Biotechnology Companies
    • Academics and Government Research Institutes
    • Others (CROs etc.)
  • Global CRISPR Technology Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Merck KGaA
    • Thermo Fisher Scientific
    • Origene Technologies, Inc.
    • New England Biolabs
    • GenScript
    • GeneCopoeia, Inc.
    • Cellecta, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Danaher Corporation (Integrated DNA Technologies)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising demand and adoption of CRISPR
    • High cost of CRISPR
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global CRISPR Technology Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global CRISPR Technology Market, By Product, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Enzymes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Guide RNA
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global CRISPR Technology Market, Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biomedical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Agricultural
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Industrial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global CRISPR Technology Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical companies and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Academics and Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others (CROs etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global CRISPR Technology Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)

9. Competitive Landscape

  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Origene Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenScript
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GeneCopoeia, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cellecta, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer, Inc. (Horizon Discovery Ltd.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation (Integrated DNA Technologies)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact